Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer
Phase of Trial: Phase I
Latest Information Update: 29 Jul 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin
- Indications Adenocarcinoma; Oesophageal cancer
- Focus Adverse reactions
- Acronyms SOX
- 26 Jul 2016 Planned End Date changed from 1 Dec 2017 to 1 Nov 2017.
- 26 Jul 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Nov 2017.
- 02 Feb 2015 New trial record